Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 491-500

  Fu, Ya Min ^a   Lin, Huimin ^a   Liu, Xiaoyi ^a   Fang, Weigang ^b   Meadows, Gary G ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; GLYCOGEN SYNTHASE KINASE 3BETA; METHIONINE; PHENYLALANINE; PROTEIN P53; PYRUVATE DEHYDROGENASE; TYROSINE; AMINO ACID; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOSPHOSERINE; PROTEIN KINASE B; PYRUVATE DEHYDROGENASE COMPLEX;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONFOCAL MICROSCOPY; CULTURE MEDIUM; GLUCOSE INTAKE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; BIOLOGICAL MODEL; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; TUMOR CELL LINE;

AMINO ACIDS; CELL DEATH; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; MALE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PHOSPHOSERINE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PYRUVATE DEHYDROGENASE COMPLEX; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953645616     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22148     Document Type: Article

References (51)

1. Almeida EAC, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, Schlaepfer DD, Damsky CH. 2000. Matrix survival signaling: From fibronectin via focal adhesion kinase to c-Jun NH2-terminal kinase. J Cell Biol 149:741-754.
2. Arbiser JL. 2004. Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: Evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Semin Cancer Biol 14:81-91.
3. Aylon Y, Oren M. 2007. Living with p53, dying of p53. Cell 130:597-600.
4. Balaban RS, Nemoto S, Finkel T. 2005. Mitochondria, oxidants, and aging. Cell 120:483-495.
5. Beurel E, KornprobstM, Blivet-Van EggelpoelMJ, Ruiz-RuizC, Cadoret A, Capeau J, Desbois-Mouthon C. 2004. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. Exp Cell Res 300:354-364.
6. Beurel E, Kornprobst M, Blivet-Van Eggelpoel MJ, Cadoret A, Capeau J, Desbois-Mouthon C. 2005. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis. Int J Oncol 27:215-222.
7. Bijur GN, Jope RS. 2003. Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 14:2415-2419.
8. Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK. 2001. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 20:6073-6083. (Pubitemid 32955050)
9. Conlon I, Raff M. 1999. Size control in animal development. Cell 96:235-244.
10. Cristofano AD, Pandolfi PP. 2000. The multiple roles of PTEN in tumor suppression. Cell 100:387-390.
11. Denmeade SR, Isaacs JT, August JT, Anders MW, Murad F, Coyle JT. 1996. Activation of programmed (apoptotic) cell death for the treatment of prostate cancer. Advances in pharmacology (Vol. 35). San Diego, CA: Academic Press, Inc. pp. 281-305.
12. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511. (Pubitemid 28553242)
13. Feng Z, Zhang H, Levine AJ, Jin S. 2005. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102:8204-8209.
14. Fu YM, Yu ZX, Pelayo BA, Ferrans VJ, Meadows GG. 1999. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res 59:758-765.
15. Fu YM, Yu ZX, Li YQ, Ge X, Sanchez PJ, Fu X, Meadows GG. 2003. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells. Nutr Cancer 45:60-73. (Pubitemid 36736893)
16. Fu YM, Zhang H, Ding M, Li YQ, Fu X, Yu ZX, Meadows GG. 2004. Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling. Clin Exp Metastasis 21:587-598. (Pubitemid 40298658)
17. Fu YM, Zhang H, Ding M, Li YQ, Fu X, Yu ZX, Meadows GG. 2006. Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells. J Cell Physiol 209:522-534. (Pubitemid 44484643)
18. Ghosh JC, Altieri DC. 2005. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res 11:4580-4588.
19. Horbinski C, Chu CT. 2005. Kinase signaling cascades in the mitochondrion: A matter of life or death. Free Radic Biol Med 38:2-11. (Pubitemid 39626903)
20. Hu P, Han Z, Couvillon AD, Exton JH. 2004. Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J Biol Chem 279:49420-49429. (Pubitemid 39625828)
21. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. 2000. Remarkable tolerance of tumor cells to nutrient deprivation: Possible new biochemical target for cancer therapy. Cancer Res 60:6201-6207.
22. Johnstone RW, Ruefli AA, Lowe SW. 2002. Apoptosis: A link between cancer genetics and chemotherapy. Cell 108:153-164.
23. Jope RS, Yuskaitis CJ, Beurel E. 2007. Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics. Neurochem Res 32:577-595. (Pubitemid 46481289)
24. Kawabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. 2001. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci 98:11563-11568.
25. Klein RD, Fischer SM. 2002. Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Carcinogenesis 23:217-221.
26. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, Liu WB, Yan Q, Gong L, Sun SM, Deng M, Liu Y. 2006a. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 25:3006-3022.
27. Li LH, Wu LJ, Tashiro SI, Onodera S, Uchiumi F, Ikejima T. 2006b. The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis. Int Immunopharmacol 6:190-197.
28. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA. 2004. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24:9993-10002.
29. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N. 2004. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16:819-830.
30. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. 2006. p53 regulates mitochondrial respiration. Science 312:1650-1653.
31. Meares GP, Jope RS. 2007. Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: Functional effects in apoptosis. J Biol Chem 282:16989-17001.
32. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T. 2000. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20:7311-7318.
33. Parise LV, Lee JW, Juliano RL. 2000.New aspects of integrin signaling in cancer. Semin Cancer Biol 10:407-414. (Pubitemid 32181911)
34. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S. 2000. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci 97:3207-3212.
35. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102:719-724.
36. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G, Boothman DA. 1995. b-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response. Cancer Res 55:3706-3711.
37. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR. 1999. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci 96:2110-2115. (Pubitemid 29117876)
38. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. 2003. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23:7315-7328.
39. Sellers WR, Fisher DE. 1999. Apoptosis and cancer drug targeting. J Clin Invest 104:1655-1661.
40. Somervaille TC, Linch DC, Khwaja A. 2001. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98:1374-1381.
41. Sonoda Y, Wanatabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. 1999. FAKIs the Upstream Signal Protein of the Phosphatidylinositol 3-Kinase-Akt Survival Pathway in Hydrogen Peroxide-induced Apoptosis of a Human Glioblastoma Cell Line. J Biol Chem 274:10566-10570. (Pubitemid 129518356)
42. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada M. 1998. Inhibition of cell migration spreading and focal adhesion by tumor suppressor PTEN. Science 280:1614-1617. (Pubitemid 28277707)
43. Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET, Yu Q. 2005. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res 65:9012-9020. (Pubitemid 41377393)
44. Tenniswood M. 1997. Apoptosis, tumour invasion and prostate cancer. Br J Urol 79:27-34.
45. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501. (Pubitemid 37328931)
46. Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS. 2003. Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J Biol Chem 278:48872-48879.
47. Weber G. 2001. Ordered biochemical program of gene expression in cancer cells. Biochemistry (Mosc) 66:1164-1173. (Pubitemid 33099919)
48. Yu LC, Flynn AN, Turner JR, Buret AG. 2005. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: A novel cellular rescue mechanism? FASEB J 19:1822-1835.
49. Yu LC, Turner JR, Buret AG. 2006. LPS/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Exp Cell Res 312:3276-3286.
50. Zheng WH, Kar S, Quirion R. 2000. Stimulation of protein kinase C modulates insulin-like growth factor-1-induced Akt activation in PC12 cells. J Biol Chem 275:13377-13385.
51. Zhou H, Li XM, Meinkoth J, Pittman RN. 2000. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biology 151:483-494.